Extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis.

Kollengode RamanathanKiran ShekarRyan Ruiyang LingRyan P BarbaroSuei Nee WongChuen Seng TanBram RochwergShannon M FernandoShinhiro TakedaGraeme MacLarenEddy FanDaniel Brodie

Published in: Critical care (London, England) (2021)

The majority of patients received venovenous ECMO support for COVID-19-related ARDS. In-hospital mortality in patients receiving ECMO support for COVID-19 was 37.1% during the first year of the pandemic, similar to those with non-COVID-19-related ARDS. Increasing age was a risk factor for death. Venovenous ECMO appears to be an effective intervention in selected patients with COVID-19-related ARDS. PROSPERO CRD42020192627.

Keyphrases

extracorporeal membrane oxygenation
coronavirus disease
acute respiratory distress syndrome
sars cov
respiratory failure
mechanical ventilation
respiratory syndrome coronavirus
end stage renal disease
randomized controlled trial
ejection fraction
peritoneal dialysis
prognostic factors